Clinical

Dataset Information

0

A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes


ABSTRACT: A Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homologous Recombination Repair (HRR) genes.

DISEASE(S): Endometrial Cancer,Solid Tumor,Lung Cancer,Sarcoma,Cervical Cancer,Colorectal Cancer,Bladder Cancer,Pancreatic Cancer,Breast Cancer,Neoplasms,Ovarian Cancer,Colon Cancer,Gastric Cancer,Esophageal Cancer,Prostate Cancer

PROVIDER: 2322588 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2015-07-14 | GSE67936 | GEO
| 9330 | ecrin-mdr-crc
2015-07-14 | E-GEOD-67936 | biostudies-arrayexpress
2018-12-19 | PXD007253 | Pride
2020-08-27 | GSE137818 | GEO
2014-07-29 | GSE57658 | GEO
2014-09-30 | GSE58041 | GEO
2010-06-11 | E-GEOD-6984 | biostudies-arrayexpress
2010-06-11 | E-GEOD-6991 | biostudies-arrayexpress
2007-02-08 | GSE6984 | GEO